应对食物过敏中的健康差异:AAAAI 预先授权工作组立场声明
自报食物过敏影响约 8% 的美国儿科人群和约 10% 的成人,少数族裔群体可能不成比例增加。食物过敏结局存在差异,低收入家庭负担可能更重,低家庭收入与更高的急诊护理支出和无过敏原食物获取不安全相关。结构性种族主义导致药物公平性问题,历史上被红线划定的社区持续面临更高水平的社区空气污染和室内过敏原暴露、就医交通缺乏、贫困以及必要药物处方率较低。临床研究需要种族和民族多样化参与以确保研究结果的普遍性和公平获得医学进步,但临床试验中的种族报告历来较差。AAAAI 等专业组织在减轻这些个体面临的挑战中可发挥重要作用,本立场声明推荐了解决这一重要问题的关键步骤。
要点
- 自报食物过敏影响约 8% 的美国儿科人群和约 10% 的成人,少数族裔群体可能不成比例增加。
- 低家庭收入与更高的急诊护理支出和无过敏原食物获取不安全相关。
- 历史上被红线划定的社区持续面临更高水平的社区空气污染和室内过敏原暴露、就医交通缺乏、贫困和必要药物处方率较低。
- 临床试验中种族报告历来较差,需要种族和民族多样化参与以确保研究结果的普遍性和公平获得医学进步。
- AAAAI 等专业组织在减轻食物过敏健康差异中可发挥重要作用,本立场声明推荐了关键步骤。
适用人群与场景
- 自报食物过敏的美国儿科人群(约 8%)和成人人群(约 10%),包括少数族裔和低收入家庭。
研究设计与关键结果
- 制定机构:AAAAI 预先授权工作组;方法:立场声明;证据分级体系:原文未报告。
- 自报食物过敏影响约 8% 的美国儿科人群和约 10% 的成人,少数族裔群体可能不成比例增加。
- 低家庭收入与更高的急诊护理支出和无过敏原食物获取不安全相关。
- 结构性种族主义部分导致药物公平性问题,历史上被红线划定的社区持续面临更高水平的社区空气污染和室内过敏原暴露、就医交通缺乏、贫困和必要药物处方率较低。
- 临床试验中种族报告历来较差,需要种族和民族多样化参与以确保研究结果的普遍性和公平获得医学进步。
- AAAAI 等专业组织在减轻食物过敏健康差异中可发挥重要作用,本立场声明推荐了关键步骤。
证据类型、等级与局限
- 证据类型:AAAAI 预先授权工作组立场声明;推荐强度:原文未给出分级标签;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应对食物过敏健康差异是临床护理的优先事项,AAAAI 等专业组织应在减轻这些个体面临的挑战中发挥重要作用。
- 作者建议采取关键步骤解决食物过敏健康差异,具体步骤见立场声明全文。
指南或共识出处
- AAAAI 预先授权工作组立场声明(Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force),发表于 J Allergy Clin Immunol。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Self-reported food allergies (FAs) affect approximately 8% of the US pediatric and approximately 10% of the adult population, which reflects potentially disproportionate increases among ethnically and racially minoritized groups. Multiple gaps and unmet needs exist regarding FA disparities. There is reported evidence of disparities in FA outcomes, and the FA burden may also be disproportionate in low-income families. Low family income has been associated with higher emergency care spending and insecure access to allergen-free food. Pharmacoinequity arises in part as a result of structural racism still experienced by historically marginalized populations today. Historically redlined communities continue to experience greater rates of neighborhood-level air pollution and indoor allergen exposure, lack of transportation to medical appointments, poverty, and lower prescription rates of necessary medications. Clinical research needs racially and ethnically diverse participation to ensure generalizability of research findings and equitable access to medical advances, but race reporting in clinical trials has been historically poor. Addressing health disparities in FA is a priority of clinical care, with professional organizations such as the American Academy of Allergy, Asthma & Immunology having a prominent role to play in mitigating the challenges faced by these individuals. In this position statement we recommend some key steps to address this important issue.
参考来源
- Addressing health disparities in food allergy: A Position Statement of the AAAAI Prior Authorization Task Force. J Allergy Clin Immunol. 2024. PMID: 39545883. doi:10.1016/j.jaci.2024.10.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。